Christine Ann Miller - 05 Jan 2023 Form 4 Insider Report for IVERIC bio, Inc.

Role
Director
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Christine Miller
Issuer symbol
N/A
Transactions as of
05 Jan 2023
Net transactions value
$0
Form type
4
Filing time
27 Feb 2023, 16:01:40 UTC
Previous filing
16 May 2022
Next filing
15 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise +5,000 5,000 05 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -5,000 -33% $0.000000 10,000 05 Jan 2023 Common Stock 5,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2 On January 5, 2022, the Reporting Person was granted 15,000 restricted stock units, which vest with respect to 1/3rd of the shares subject to the award in annual installments until the third anniversary of the grant date, subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions of the Registrant's 2013 Stock Incentive Plan.